Tokyo, July 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062096) titled 'International prospective observational study of cardiovascular imaging in inflammatory cardiovascular diseases' on July 1.

Study Type: Observational

Primary Sponsor: Institute - Juntendo University

Condition: Condition - inflammatory cardiovascular diseases Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Inflammatory cardiovascular diseases (ICARDs) encompass a broad spectrum of conditions, including myocarditis, pericarditis, vasculitis, and cardiovascular involvement associated with connective tissue diseases. However, evidence regarding the diagnostic and prognostic value of multimodality cardiovascular imaging remains limited. This international prospective observational study aims to evaluate the diagnostic and prognostic utility of multimodality cardiovascular imaging, including echocardiography, computed tomography, cardiac magnetic resonance imaging, and nuclear imaging, using real-world clinical data, and to provide evidence for the development of standardized diagnostic algorithms and optimal management strategies for ICARDs. Basic objectives2 - Others

Eligibility: Age-lower limit - 18 years-old =18 years.

2. Patients undergoing cardiac magnetic resonance imaging (CMR) or nuclear imaging for one of the following suspected or confirmed inflammatory cardiovascular diseases (ICARDs): - Myocarditis (acute or chronic, regardless of etiology) - Myocardial infarction with non-obstructive coronary arteries (MINOCA) - Takotsubo syndrome - Pericarditis (acute or chronic, regardless of etiology) - Connective tissue diseases with cardiovascular involvement - Systemic sclerosis - Systemic lupus erythematosus - Antiphospholipid syndrome - Idiopathic inflammatory myopathies - Rheumatoid arthritis or spondyloarthritis - Vasculitis with cardiovascular involvement (including ANCA-associated vasculitis, Behcet disease, and Takayasu arteritis) - Inflammatory diseases with cardiovascular involvement (including sarcoidosis and Still's disease) Key exclusion criteria - Patients with a history of heart transplantation Target Size - 5000

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2025 Year 12 Month 05 Day Date of IRB - 2025 Year 12 Month 05 Day Anticipated trial start date - 2025 Year 12 Month 05 Day Last follow-up date - 2031 Year 06 Month 04 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071050

Disclaimer: Curated by HT Syndication.